Atara Biotherapeutics
ATRA
ATRA
117 hedge funds and large institutions have $1.01B invested in Atara Biotherapeutics in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 4.39% → 4.52% (+0.12%)
43% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $2.13M
Holders
117
Holding in Top 10
1
Calls
$1.22M
Puts
$2.13M
Top Buyers
| 1 | +$29.3M | |
| 2 | +$6.99M | |
| 3 | +$6.94M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.51M |
| 5 |
PA
Pinnacle Associates
New York
|
+$5.34M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$13.8M | |
| 3 | -$7.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.68M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.38M |